Objective To observe the value of ultrasound soft markers at 11-14 weeks of gestation for predicting adverse pregnancy outcomes using meta-analysis.Methods Literature about ultrasound soft markers at 11-14 weeks of gestation,including nuchal translucency(NT)thickening,nasal bone dysplasia,reversed or absent venous duct,tricuspid regurgitation and single umbilical artery,for predicting adverse pregnancy outcomes were searched in CNKI,Wanfang Med Online,VIP databases,PubMed,Cochrane Library,Embase and Web of Science databases from January 1,2000 to April 1,2024 by 2 researchers independently.The data were extracted,and the risk of bias was assessed.Stata 17.0 software was used for meta-analysis.Results Totally 37 articles involving 9 673 gravidas were enrolled.Meta-analysis showed that the more positive ultrasound soft markers at 11-14 weeks of gestation,the higher risk of adverse pregnancy outcomes.Among single positive markers,single umbilical artery had the highest incidence of adverse pregnancy outcomes,and NT≥3.0 mm had the highest incidence of chromosome abnormalities in fetuses,while tricuspid regurgitation suggested the lowest possibility of adverse pregnancy outcomes and chromosome abnormalities in fetuses.Conclusion Positive ultrasound soft markers at 11-14 weeks of gestation had certain predictive value for adverse pregnancy outcomes,especially chromosomal abnormalities.

Objective To observe the value of ultrasound soft markers at 11-14 weeks of gestation for predicting adverse pregnancy outcomes using meta-analysis.Methods Literature about ultrasound soft markers at 11-14 weeks of gestation,including nuchal translucency(NT)thickening,nasal bone dysplasia,reversed or absent venous duct,tricuspid regurgitation and single umbilical artery,for predicting adverse pregnancy outcomes were searched in CNKI,Wanfang Med Online,VIP databases,PubMed,Cochrane Library,Embase and Web of Science databases from January 1,2000 to April 1,2024 by 2 researchers independently.The data were extracted,and the risk of bias was assessed.Stata 17.0 software was used for meta-analysis.Results Totally 37 articles involving 9 673 gravidas were enrolled.Meta-analysis showed that the more positive ultrasound soft markers at 11-14 weeks of gestation,the higher risk of adverse pregnancy outcomes.Among single positive markers,single umbilical artery had the highest incidence of adverse pregnancy outcomes,and NT≥3.0 mm had the highest incidence of chromosome abnormalities in fetuses,while tricuspid regurgitation suggested the lowest possibility of adverse pregnancy outcomes and chromosome abnormalities in fetuses.Conclusion Positive ultrasound soft markers at 11-14 weeks of gestation had certain predictive value for adverse pregnancy outcomes,especially chromosomal abnormalities.

Objective:To develop a quantitative HPLC-MS/MS method for the determination of astragulin and kaempferol in Bairui granule. Methods:A column of Ultimate XB-C C18(100 mm×2.1 mm,5 μm)was used. The mobile phase was composed of 0.1% formic acid-water(A) and 0.1% formic acid-acetonitrile(B) with gradient elution. The flow rate was 0.3 ml·min-1. The detection was performed with multiple teactions monitoring (MRM) using electrospray ionization (ESI). The precursor/product ion transitions were monitored at m/z 447.2→m/z 284.0 (anion mode) for astragulin and m/z 285.1→m/z 187.1 (anion mode) for kaempferol. The temperature of column was set at 40℃. Results:A good linearity was obtained with the concentration ranging from 9.86 to 1 970 ng·ml-1(r=0.999 5) for astragulin and 8.73 to 437 ng·ml-1(r=0.999 6) for kaempferol. The average recovery of the two inves-tigated compounds at low, medium and high concentrations was 99.23%, 99.65% and 99.23%, and 98.24%, 99.13% and 99.69% with the RSD of 1.84%,1.37% and 1.21%,and 1.38%,0.96% and 1.47%, respectively (n=6). Conclusion: The method is rapid,accurate and reliable,which can be used to control the quality of Bairui granule.

Objective To evaluate postprandial pharmacokinetics and bioequivalence of two preparations of cefdinir capsules in Chinese healthy volunteers. Methods In a two-way cross-over study, 24 healthy male volunteers were divided into two groups randomly and a single dose of cefdinir capsules of test and reference preparation were administered orally, respectively.The concentration in plasma was determined by LC-MS/MS. Pharmacokinetic parameters and bioequivalence were calculated and evaluated by DAS. Results The main pharmacokinetic parameters of test and reference were as follows: AUCt (4.35±1.09) μg??h??mL-1 and (4.12±1.22) μg??h??mL-1, AUC0-∞(4.53±1.12) and (4.53±1.73) μg??h??mL-1, t1/2 (1.74±0.29) h and (2.13±1.65) h, tmax(4.44±0.86) h and (4.54 ±1.16) h, Cmax(900±250) ng??mL-1 and (876±269) ng??mL-1 . Conclusion The test and reference preparation of cefdinir capsules are bioequivalent.